Medical specialists from France tagged as investigators in clinical trials studying Triple Negative Breast Neoplasms
Total 44 results
-
Adeline MOREL, MDSeen in:
- Caen, Centre Francois Baclesse
Trials:- NCT04554927 (Sub-Investigator)
- NCT05404321 (Sub-Investigator)
- NCT05414357 (Sub-Investigator)
-
Adeline PETIT, MDSeen in:
- Bordeaux, Institut Bergonie
Trials:- NCT03017573 (Principal Investigator)
-
Alain TOLEDANOSeen in:
- Paris, H. Hartmann Institute of Radiotherapy and Radiosurgery
Trials:- NCT02806258 (Principal Investigator)
-
Alison JOHNSON, MDSeen in:
- Caen, Centre Francois Baclesse
Trials:- NCT04554927 (Sub-Investigator)
- NCT05404321 (Sub-Investigator)
Conditions: -
Antoine ITALIANO, MD, PhDSeen in:
- Bordeaux, Institut Bergonie
Trials:- NCT03475953 (Sub-Investigator)
Conditions:- Hepatocellular Carcinoma;
- Triple Negative Breast Cancer;
- Non-small Cell Lung Cancer;
- Soft-tissue Sarcoma;
- Urothelial Carcinoma;
- Thyroid Cancer;
- Gastro-enteropancreatic Neuroendocrine Tumor;
- Biliary Tract Cancer;
- HPV-Related Carcinoma;
- Solid Tumor, Adult;
- Mesotheliomas Pleural;
- GIST;
- Renal Carcinoma;
- Colorectal Cancer Not MSI-H or MMR-deficient;
- Oesophageal or Gastric Carcinoma
-
Audrey FAVEYRIAL, MDSeen in:
- Caen, Centre Francois Baclesse
Trials:- NCT04554927 (Sub-Investigator)
- NCT05404321 (Sub-Investigator)
Conditions: -
Aurélien Marabelle, M.D.Seen in:
- Paris, Gustave Roussy
Trials:- NCT04432857 (Principal Investigator)
-
Camille PASQUESOONE, MDSeen in:
- Lille, Centre OSCAR LAMBRET
Trials:- NCT03017573 (Principal Investigator)
-
Carine SEGURA, MDSeen in:
- Caen, Centre Francois Baclesse
Trials:- NCT04554927 (Sub-Investigator)
- NCT05404321 (Sub-Investigator)
Conditions: -
Carlos Alberto GOMEZ-ROCA, MDSeen in:
- Toulouse, IUCT Oncopole
Trials:- NCT03915678 (Principal Investigator)
-
Christelle LEVY, MDSeen in:
- Caen, Centre Francois Baclesse
Trials:- NCT04554927 (Sub-Investigator)
- NCT05404321 (Sub-Investigator)
- NCT05414357 (Sub-Investigator)
-
Christophe Le TourneauSeen in:
- Other, Paris cedex 05, Institut Curie
- Paris, GSK Investigational Site
- Paris, Institut Curie
Trials:- NCT03088059 (Principal Investigator)
- NCT05208762 (Principal Investigator)
- NCT06062420 (Principal Investigator)
- NCT03526835 (Principal Investigator)
- NCT02029001 (Principal Investigator)
- NCT04116541 (Principal Investigator)
- NCT05605496 (Principal Investigator)
- NCT03017573 (Principal Investigator)
Conditions:- Carcinoma, Squamous Cell of Head and Neck;
- Melanoma;
- Carcinoma, Non-Small-Cell Lung;
- Gastric Cancer;
- Ovarian Neoplasms;
- Squamous Cell Carcinoma of the Head and Neck;
- Triple Negative Breast Neoplasms;
- Esophageal Squamous Cell Carcinoma;
- Neoplasms, Head and Neck;
- Colorectal Cancer;
- NSCLC;
- Head and Neck Squamous Cell Carcinoma;
- HNSCC;
- Advanced/Metastatic Solid Tumors;
- Gastroesophageal-junction Cancer;
- Malignant Solid Neoplasms;
- Malignant Solid Tumor;
- Advanced Solid Tumors;
- Metastatic Solid Tumors;
- Cervical Cancer;
- Head and Neck Cancer;
- Ovarian Cancer;
- Triple-Negative Breast Cancer
-
David PASQUIER, MDSeen in:
- Lille Cedex, Centre OSCAR LAMBRET
- Lille, Centre OSCAR LAMBRET
Trials:- NCT04536805 (Principal Investigator)
- NCT04498767 (Principal Investigator)
- NCT03915678 (Principal Investigator)
Conditions:- Prostate Cancer;
- Melanoma;
- Sarcoma;
- Head and Neck Cancer;
- Gynecologic Cancer;
- Gastric Cancer;
- Pancreatic Cancer;
- Esophageal Cancer;
- Small Bowel Cancer;
- Bladder Cancer;
- Skin Cancer;
- Colon Cancer;
- Renal Cancer;
- Oligometastasis;
- Hepatobiliary Cancer;
- Upper Urinary Tract Carcinoma;
- Non Small Cell Lung Cancer;
- Triple Negative Breast Cancer;
- Solid Tumor, Adult;
- Virus-associated Tumors
-
Djelila ALLOUACHE, MDSeen in:
- Caen, Centre Francois Baclesse
Trials:- NCT04554927 (Sub-Investigator)
- NCT05404321 (Sub-Investigator)
Conditions: -
Dr CassierSeen in:
- Lyon, Centre LEON BERARD
Trials:- NCT04725331 (Principal Investigator)
-
Dr ChampiatSeen in:
- Villejuif, Institut Gustave Roussy
Trials:- NCT04725331 (Principal Investigator)
-
E. Romano, MDSeen in:
- Paris, Institut Curie
Trials:- NCT05403554 (Principal Investigator)
-
François GHIRINGHELLI, MD, PhDSeen in:
- Dijon, Centre Georges Francois Leclerc
Trials:- NCT03915678 (Principal Investigator)
-
Francois-Clement BidardSeen in:
- Hauts-de-Seine, Saint-Cloud, Institut Curie - site Saint-Cloud
- Paris, Institut Curie
- Saint Cloud, Institut Curie
- Saint-Cloud, Institut Curie
- Île-de-France, Saint-Cloud, Institut Curie
Trials:- NCT04975308 (Principal Investigator)
- NCT05514054 (Principal Investigator)
- NCT05932667 (Principal Investigator)
- NCT06162351 (Principal Investigator)
- NCT06337630 (Principal Investigator)
- NCT06175390 (Principal Investigator)
-
George EMILE, MDSeen in:
- Caen, Centre Francois Baclesse
Trials:- NCT05404321 (Principal Investigator)
Conditions: -
Ioana HRAB, MDSeen in:
- Caen, Centre Francois Baclesse
Trials:- NCT04554927 (Sub-Investigator)
- NCT05404321 (Sub-Investigator)
Conditions: -
Isabelle GABELLE-FLANDIN, DrSeen in:
- Grenoble Cedex 09, CHU de Grenoble
Trials:- NCT02806258 (Principal Investigator)
-
J. Medioni, MDSeen in:
- Paris, Hopital Europeen Georges Pompidou
Trials:- NCT05403554 (Principal Investigator)
-
Jean-Philippe METGES, MD,PhDSeen in:
- Brest, CHU Brest
Trials:- NCT03915678 (Principal Investigator)
-
Julien GEFFRELOT, MDSeen in:
- Caen, Centre Francois Baclesse
Trials:- NCT04554927 (Sub-Investigator)
- NCT03663725 (Sub-Investigator)
- NCT05404321 (Sub-Investigator)
- NCT05082961 (Sub-Investigator)
- NCT06036706 (Sub-Investigator)
-
Laurent ZELEK, PrSeen in:
- Paris, CHU Avicenne
Trials:- NCT02806258 (Principal Investigator)
-
Laurie MONIIERSeen in:
- Paris, Tenon Hospital
Trials:- NCT02806258 (Principal Investigator)
-
Loic Verligue, MDSeen in:
- Lyon, Centre LEON BERARD
Trials:- NCT04561362 (Principal Investigator)
Clinical Trials on Triple Negative Breast Neoplasms
-
Peregrine PharmaceuticalsWithdrawnBreast Cancer | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | Triple-Negative Breast Cancer | Triple-Negative Breast Neoplasm | ER-Negative PR-Negative HER2-Negative Breast Neoplasms | ER-Negative PR-Negative HER2-Negative Breast Cancer
-
Washington University School of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH); MedImmune...TerminatedTriple Negative Breast Cancer | Triple Negative Breast Neoplasms | TNBC - Triple-Negative Breast Cancer | Triple-negative Breast CarcinomaUnited States
-
G1 Therapeutics, Inc.TerminatedBreast Cancer | Breast Neoplasm | Triple-Negative Breast Cancer | Triple-Negative Breast NeoplasmsUnited States, Bulgaria, Croatia, Slovenia, Serbia, Belgium, North Macedonia, Slovakia
-
Swiss Group for Clinical Cancer ResearchNot yet recruitingTriple-negative Breast Cancer | TNBC - Triple-Negative Breast CancerSwitzerland
-
AkesoRecruitingMetastatic Triple-negative Breast Cancer | Locally Advanced Triple-negative Breast CancerChina
-
Jiangxi Provincial Cancer HospitalRecruitingTriple-Negative Breast CancerChina
-
Fudan UniversityNot yet recruitingTriple-negative Breast Cancer
-
Fudan UniversityRecruitingTriple-Negative Breast CancerChina
-
Fudan UniversityRecruiting
-
Fudan UniversityRecruiting